首页|miR-19a靶向胰岛素样生长因子2受体抑制血管瘤干细胞的增殖和迁移

miR-19a靶向胰岛素样生长因子2受体抑制血管瘤干细胞的增殖和迁移

扫码查看
目的 探讨婴儿血管瘤(IHs)中miR-19a是否与胰岛素样生长因子2受体(IGF-2R)相互作用,影响血管瘤干细胞(HemSCs)的增殖、迁移和脂肪生成。方法 从IHs标本中分离、筛选和培养HemSCs,免疫组织化学鉴定IGF-2R在HemSCs中表达。用miR-19a模拟物和抑制剂对HemSCs进行转染,通过CCK-8、划痕实验、Transwell、qRT-PCR和免疫印迹相关实验验证miR-19a对于HemSCs增殖与迁移的影响。结果 与对照组相比,用miR-19a抑制剂处理的Hem-SCs增殖与迁移速度显著增加,miR-19a过表达显著抑制IGF-2诱导的细胞迁移和增殖(P<0。05)。结论 miR-19a可能通过靶向IGF-2R抑制HemSCs的增殖、迁移和脂肪生成。
MiR-19a affects hemangioma stem cells proliferation and migration by targeting insulin-like growth factor 2 receptor
Objective To investigate whether miR-19a interacts with insulin-like growth factor 2 receptors(IGF-2R)in infantile hemangiomas(IHs)and affects the proliferation,migration,and adipogenesis of hemangioma stem cells(HemSCs).Methods HemSCs were isolated,screened and cultured from IH specimens.IGF-2R expression in HemSCs was identified using immunohistochemistry.HemSCs transfected with miR-19a mimics and inhibitors were subjected to CCK-8,wound healing,Transwell,qRT-PCR,and Western blot analyses.Results Compared with the control,the proliferation and migration rate of HemSCs treated with miR-19a inhibitors were significantly increased,and overexpression of miR-19a significantly inhibited IGF-2 induced cell migration and proliferation(P<0.05).Conclusion MiR-19a may inhibit HemSCs proliferation,migration,and adipogenesis by targeting IGF-2R.

hemangioma stem cellsmicroRNAIGF-2Rproliferationmigration

汪帆、吴瑶、方林森、曹东升

展开 >

安徽医科大学第一附属医院北区(安徽省公共临床中心)创面修复与整形美容外科,合肥 230001

安徽医科大学第二附属医院创面修复与整形美容外科,合肥 230001

血管瘤干细胞 微小RNA IGF-2R 增殖 迁移

安徽省自然科学基金项目安徽医科大学科研基金项目

1808085mh2822019xkj062

2024

安徽医科大学学报
安徽医科大学

安徽医科大学学报

CSTPCD北大核心
影响因子:1.095
ISSN:1000-1492
年,卷(期):2024.59(6)
  • 15